Thumbnail Image
Publication

Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012.

Akmatov, Manas K
; 
Stumme, Melanie
; 
Pessler, Frank
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2016-08-30
Submitted date
Show all metadata
Files
Thumbnail Image
original manuscript
Adobe PDF, 524.61 KB
Other Titles
Abstract
Methotrexate (MTX) is used at low doses to treat rheumatologic disorders in the paediatric age group. Toxicity is observed despite the low doses used. Even though recommendations for monitoring of early signs of toxicity exist in many countries, real-life practice may vary. We therefore assessed current practice in Germany, Switzerland and Austria.
Citation
Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012., 34 (3):548-53 Clin. Exp. Rheumatol.
Affiliation
TWINCORE Centre for Experimental and Clinical Infection Research Feodor-Lynen-Str. 7 30625 Hannover, Germany.
Publisher
Journal
Clinical and experimental rheumatology
URI
http://hdl.handle.net/10033/619049
DOI
PubMed ID
27156925
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
0392-856X
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Collections
publications of the research group biomarker in infection and immunity [[TC] BIOM)